Last checked at 18 May 2021 17:00
LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data
LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oxford Biomedica Share News (OXB)
OXB Share
Price
OXB Share
News
OXB Share
Chat
OXB Share
Trades322
OXB
Live RNS
OXB Share
Charts
OXB Level 2
Console
OXB Live
Share Price
OXB Broker
Ratings
OXB Directors
Deals
OXB Financial
Diary
OXB
Fundamentals
OXB Short
Positions
OXB
Media
Oxford Biomedica Information
Share Price Information for Oxford Biomedica (OXB)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
228.50
Bid:
228.50
Ask:
231.00
Change:
8.50 (3.86%)
Spread:
2.50 (1.094%)
Open:
222.00
High:
234.00
Low:
221.00
Prev. Close:
220.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 May 2021 12:12
LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42
LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42
Read more18 May 2021 11:52
Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines
Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines
Read more18 May 2021 09:23
UPDATE 2-FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Oxford Biomedica rises on robust outlook* Vodafone drops after missing earnings expectations* FTSE 100 up 0.2%, FTSE 250 adds 0.6% (Update...
Read more18 May 2021 08:45
LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark
LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark
Read more18 May 2021 08:13
Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output
(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Read more18 May 2021 07:47
LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale
LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale
Read more28 Apr 2021 09:23
UPDATE 2-EU demands immediate access to UK-made vaccines in AstraZeneca legal battle
* EU demands faster deliveries in first hearing of legal case* AstraZeneca says lower supplies not in breach of contract* EU, UK vie for doses, Astra has under-delivered to both* Next hearings on May 26, EU seeks verdict before end of June (recast...
Read more16 Apr 2021 09:49
BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone
BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone
Read more15 Apr 2021 09:02
Oxford Biomedica swings to EBITDA profit
(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.
Read more15 Apr 2021 09:00
Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal
Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal
Read more8 Apr 2021 16:05
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more6 Apr 2021 08:19
Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim
Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim
Read more6 Apr 2021 08:08
Oxford Biomedica strikes three-year deal with Boehringer Ingelheim
(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.
Read more6 Apr 2021 07:53
LONDON MARKET PRE-OPEN: Returns in store for BP shareholders
LONDON MARKET PRE-OPEN: Returns in store for BP shareholders
Read more